Request Free Sample
×
Germany Morphine Market
ID: MRFR/HC/49739-HCR
200 Pages
May 2025
Germany Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035
Industry Developments
Recent developments in the Germany Morphine Market have shown continued focus on regulatory frameworks and innovation in pain management solutions by major players such as Teva Pharmaceutical Industries, Mundipharma, and GSK. In October 2023, Fresenius Kabi introduced an enhanced formulation of a morphine-based analgesic, aimed at improving patient compliance and therapeutic outcomes. Current regulatory trends emphasize stringent measures against misuse and over-prescription, reflecting Germany's commitment to responsible opioid use. Over the past few years, notable mergers have reshaped the landscape; for instance, in March 2022, Abbott Laboratories acquired a division of Acerta Pharma from AstraZeneca to expand its pain management portfolio, indicating a strategic move into the morphine segment. Additionally, growth in market valuation has been apparent, with AbbVie reporting a significant increase in its revenue contributions from pain management drugs in their latest fiscal year report. The competitive landscape is further intensified by the entry of generic alternatives from companies like Sandoz and Hikma Pharmaceuticals, fostering price competition and greater availability of morphine products in the German market. These trends highlight both challenges and opportunities within the evolving Germany Morphine Market.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.01(USD Billion) |
| MARKET SIZE 2024 | 1.2(USD Billion) |
| MARKET SIZE 2035 | 2.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.753% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Teva Pharmaceutical Industries, Mundipharma, GSK, Eli Lilly, Fresenius Kabi, AbbVie, AptarGroup, Sandoz, AstraZeneca, Hikma Pharmaceuticals, Roche, Boehringer Ingelheim, Pfizer, Baxter International |
| SEGMENTS COVERED | Dosage Form, Application, Distribution Channel, End User |
| KEY MARKET OPPORTUNITIES | Increased cancer care demand, Expanded palliative care services, Growth in chronic pain management, Rising elderly population need, Innovative delivery methods development |
| KEY MARKET DYNAMICS | Regulatory compliance and restrictions, Increasing chronic pain prevalence, Opioid addiction concerns, Technological advancements in drug delivery, Growing demand for palliative care |
| COUNTRIES COVERED | Germany |
FAQs
What is the projected market size of the Germany Morphine Market in 2024?
The projected market size of the Germany Morphine Market in 2024 is valued at 1.2 billion USD.
What is the expected market size for the Germany Morphine Market by 2035?
The expected market size for the Germany Morphine Market by 2035 is valued at 2.0 billion USD.
What is the expected CAGR for the Germany Morphine Market from 2025 to 2035?
The expected CAGR for the Germany Morphine Market from 2025 to 2035 is 4.753 percent.
Which segment of the Germany Morphine Market is expected to grow the most?
The injection segment of the Germany Morphine Market is anticipated to grow significantly, reaching 0.8 billion USD by 2035.
What is the market size of the oral dosage form of morphine in Germany for 2024?
The market size of the oral dosage form of morphine in Germany for 2024 is valued at 0.36 billion USD.
Who are the key players in the Germany Morphine Market?
Key players in the Germany Morphine Market include Teva Pharmaceutical Industries, Mundipharma, GSK, and Eli Lilly.
What is the market potential for other dosage forms of morphine by 2035?
The market potential for other dosage forms of morphine is expected to reach 0.6 billion USD by 2035.
What are the key growth drivers for the Germany Morphine Market?
Key growth drivers for the Germany Morphine Market include increasing demand for pain management solutions and advancements in drug formulation.
How is the injection segment performing in the Germany Morphine Market?
The injection segment is valued at 0.48 billion USD in 2024 and is forecasted to grow to 0.8 billion USD by 2035.
What challenges does the Germany Morphine Market face?
Challenges in the Germany Morphine Market include regulatory hurdles and the emergence of alternative pain management therapies.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment